Sight Sciences Announces the Closing of its $7MM Series B Financing Led by Hicks Equity Partners

Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company today announced it has closed a $7 million Series B round of financing. The round was led by Hicks Equity Partners, a leading private equity firm based in Dallas, Texas. All Series A investors participated in the oversubscribed Series B round, including Scientific Health Development (Series A Co-Lead), Allegro Investment Fund, and various other institutional and angel investors.